Constellation Pharmaceuticals, Inc. Debt to Equity Ratio 2018-2021 | CNST
Current and historical debt to equity ratio values for Constellation Pharmaceuticals, Inc. (CNST) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Constellation Pharmaceuticals, Inc. debt/equity for the three months ending March 31, 2021 was .
| Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2021-03-31 | $0.03B | $0.38B | 0.07 |
| 2020-12-31 | $0.03B | $0.41B | 0.08 |
| 2020-09-30 | $0.06B | $0.44B | 0.14 |
| 2020-06-30 | $0.06B | $0.47B | 0.13 |
| 2020-03-31 | $0.06B | $0.32B | 0.18 |
| 2019-12-31 | $0.06B | $0.34B | 0.18 |
| 2019-09-30 | $0.06B | $0.05B | 1.19 |
| 2019-06-30 | $0.05B | $0.07B | 0.70 |
| 2019-03-31 | $0.04B | $0.09B | 0.45 |
| 2018-12-31 | $0.02B | $0.10B | 0.14 |
| 2018-09-30 | $0.01B | $0.12B | 0.09 |
| 2018-06-30 | $0.01B | $0.09B | 0.12 |
| 2018-03-31 | $0.00B | 0.00 | |
| 2017-09-30 | $0.00B | 0.00 | |
| 2017-06-30 | $0.00B | 0.00 | |
